1,2-distearoyllecithin has been researched along with celecoxib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banerjee, S; Sade, A; Severcan, F | 1 |
| Banerjee, S; Erdoğ, A; Keskin, D; Putra Limasale, YD; Tezcaner, A | 1 |
2 other study(ies) available for 1,2-distearoyllecithin and celecoxib
| Article | Year |
|---|---|
Concentration-dependent differing actions of the nonsteroidal anti-inflammatory drug, celecoxib, in distearoyl phosphatidylcholine multilamellar vesicles.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Celecoxib; Drug Carriers; Drug Delivery Systems; Liposomes; Nephelometry and Turbidimetry; Phosphatidylcholines; Pyrazoles; Sulfonamides; Temperature | 2010 |
In vitro characterization of a liposomal formulation of celecoxib containing 1,2-distearoyl-sn-glycero-3-phosphocholine, cholesterol, and polyethylene glycol and its functional effects against colorectal cancer cell lines.
Topics: Celecoxib; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Cholesterol; Colorectal Neoplasms; Drug Delivery Systems; HCT116 Cells; HT29 Cells; Humans; Liposomes; Phosphatidylcholines; Polyethylene Glycols; Pyrazoles; Sulfonamides | 2013 |